Christine J. Ko

Christine J. Ko

Auto-generated profile, based on publicly available information

Christine J. Ko

Department of Dermatology Yale School of Medicine New Haven Connecticut USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
CKChristine J Ko
Christine J Ko
DEDirk M Elston
Dirk M Elston

1 August 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
YLYoung H. Lim
Young H. Lim
ABAntonella Bacchiocchi
Antonella Bacchiocchi
JQJingyao Qiu
Jingyao Qiu
RSRobert Straub
Robert Straub
ABAnna Bruckner
Anna Bruckner
KCKeith A. Choate
Keith A. Choate

1 May 2016 in JAAD Case Reports
Verified
Journal Article
Open access
KSKathleen C. Suozzi
Kathleen C. Suozzi
MSMaximilian Stahl
Maximilian Stahl
CKChristine J. Ko
Christine J. Ko
ACAnne Chiang
Anne Chiang
SGScott N. Gettinger
Scott N. Gettinger
CBChristopher G. Bunick
Christopher G. Bunick

1 May 2010 in Clinics in Dermatology
Verified
Journal Article
Closed access
CKChristine J. Ko
Christine J. Ko

1 June 2015 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
PDF file
YLYoung H. Lim
Young H. Lim
SDStephanie R. Douglas
Stephanie R. Douglas
CKChristine J. Ko
Christine J. Ko
RARichard J. Antaya
Richard J. Antaya
JMJennifer M. McNiff
Jennifer M. McNiff
DNDeepak Narayan
Deepak Narayan
Vascular anomalies comprise a spectrum of lesions subdivided into malformations and tumors by clinical behavior and histological features. Vascular malformations demonstrate slow progression, whereas vascular tumors proliferate rapidly with marked endothelial turnover ( Enjolras et al., 2007 x Enjolras et al., 2007 Enjolras, O., Wassef, M., and Chapot, R. Introduction: ISSVA Classification. Cambridge University Press, Cambridge, UK; 2007 Google Scholar See all References Enjolras et al., 2007 ). Definitive diagnosis can be challenging, as lesion characteristics may not conform to existing classifications. Hence, many vascular anomalies are identified descriptively ( Enjolras et al., 2007 x Enjolras et al., 2007 Enjolras, O., Wassef, M., and Chapot, R. Introduction: ISSVA Classification. Cambridge University Press, Cambridge, UK; 2007 Google Scholar See all References Enjolras et al., 2007 ). “Lobular capillary hemangioma” describes a vascular tumor with lobular architecture, including infantile hemangiomas (IHs) and other vascular lesions with lobules of proliferating endothelial cells, although the term is commonly used interchangeably for pyogenic granuloma (PG) ( Enjolras et al., 2007 x Enjolras et al., 2007 Enjolras, O., Wassef, M., and Chapot, R. Introduction: ISSVA Classification. Cambridge University Press, Cambridge, UK; 2007 Google Scholar See all References Enjolras et al., 2007 ). PGs are benign, spontaneous vascular tumors with small vessels organized in lobules ( Giblin et al., 2007 x Giblin et al., 2007 Giblin, A.V., Clover, A.J., Athanassopoulos, A. et al. Pyogenic granuloma - the quest for optimum treatment: audit of treatment of 408 cases. J Plast Reconstr Aesthet Surg. 2007; 60: 1030–1035 Abstract | Full Text | Full Text PDF | PubMed | Scopus (60) | Google Scholar See all References Giblin et al., 2007 ). Approximately 0.5% of skin nodules and 10% of head and neck hemangiomas are PGs, which often develop in children and adolescents and up to 5% of pregnant women, although rare congenital, disseminated cases occur ( Giblin et al., 2007 x Giblin et al., 2007 Giblin, A.V., Clover, A.J., Athanassopoulos, A. et al. Pyogenic granuloma - the quest for optimum treatment: audit of treatment of 408 cases. J Plast Reconstr Aesthet Surg. 2007; 60: 1030–1035 Abstract | Full Text | Full Text PDF | PubMed | Scopus (60) | Google Scholar See all References Giblin et al., 2007 ; Browning et al., 2009 x Browning et al., 2009 Browning, J.C., Eldin, K.W., Kozakewich, H.P. et al. Congenital disseminated pyogenic granuloma. Pediatr Dermatol. 2009; 26: 323–327 Crossref | PubMed | Scopus (19) | Google Scholar See all References Browning et al., 2009 ). Lesions appear as dome-shaped, bright red or blue protrusions that grow rapidly and are prone to hemorrhage ( Enjolras et al., 2007 x Enjolras et al., 2007 Enjolras, O., Wassef, M., and Chapot, R. Introduction: ISSVA Classification. Cambridge University Press, Cambridge, UK; 2007 Google Scholar See all References Enjolras et al., 2007 ). PGs primarily occur on cutaneous or mucosal surfaces of the head, neck, and upper extremities, although cases within the gastrointestinal tract, urinary tract, eye, and the central nervous system have been reported ( Ahuja et al., 2013 x Ahuja et al., 2013 Ahuja, T., Jaggi, N., Kalra, A. et al. Hemangioma: review of literature. J Contemp Dent Prac. 2013; 14: 1000–1007 Crossref | PubMed | Scopus (1) | Google Scholar See all References Ahuja et al., 2013 ). Although infection, trauma, and angiogenic factor upregulation have been proposed, the etiology of PG remains unknown ( Giblin et al., 2007 x Giblin et al., 2007 Giblin, A.V., Clover, A.J., Athanassopoulos, A. et al. Pyogenic granuloma - the quest for optimum treatment: audit of treatment of 408 cases. J Plast Reconstr Aesthet Surg. 2007; 60: 1030–1035 Abstract | Full Text | Full Text PDF | PubMed | Scopus (60) | Google Scholar See all References Giblin et al., 2007 ; Ahuja et al., 2013 x Ahuja et al., 2013 Ahuja, T., Jaggi, N., Kalra, A. et al. Hemangioma: review of literature. J Contemp Dent Prac. 2013; 14: 1000–1007 Crossref | PubMed | Scopus (1) | Google Scholar See all References Ahuja et al., 2013 ).

26 March 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
GZGiovanni Zito
Giovanni Zito
ISIchiko Saotome
Ichiko Saotome
ZLZongzhi Liu
Zongzhi Liu
EFEnrico G. Ferro
Enrico G. Ferro
TSThomas Y. Sun
Thomas Y. Sun
VGValentina Greco
Valentina Greco
A fundamental goal in cancer biology is to identify the cells and signalling pathways that are keys to induce tumour regression. Here we use a spontaneously self-regressing tumour, cutaneous keratoacanthoma (KAs), to identify physiological mechanisms that drive tumour regression. By using a mouse model system that recapitulates the behaviour of human KAs, we show that self-regressing tumours shift their balance to a differentiation programme during regression. Furthermore, we demonstrate that developmental programs utilized for skin hair follicle regeneration, such as Wnt, are hijacked to sustain tumour growth and that the retinoic acid (RA) signalling pathway promotes tumour regression by inhibiting Wnt signalling. Finally, we find that RA signalling can induce regression of malignant tumours that do not normally spontaneously regress, such as squamous cell carcinomas. These findings provide new insights into the physiological mechanisms of tumour regression and suggest therapeutic strategies to induce tumour regression.